treatment of disease progression after first line cdk4/6 inhibitors by dr. omalkhair abulkhair
Published 3 years ago • 70 plays • Length 17:00Download video MP4
Download video MP3
Similar videos
-
8:42
hr mbc: treatment after progression on cdk4/6 inhibition
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
1:17:18
changing standards of care for use of cdk4 and 6 inhibitors in the treatment of breast cancer
-
2:17
dr. goetz on treatment beyond progression on cdk4/6 inhibitors in hr breast cancer
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
26:34
cdk 4/6 inhibitors in breast cancer advanced and adjuvant settings
-
3:14
cdk4/6 inhibitor with aromatase inhibitors for hormone receptor positive breast cancer
-
5:29
treatment after progression on cdk 4/6i in mbc
-
1:02:43
realizing the potential of cdk 4/6 inhibitor therapy in breast cancer: real-world data and evidence
-
3:57
cdk 4/6 inhibitor as first-line therapy for advanced breast cancer
-
5:28
treatment after progression on cdk 4/6i in mbc
-
4:17
cdk4/6 inhibitors & endocrine therapy in breast cancer
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
6:15
breast cancer at esmo 2020: cdk4/6 inhibitors and checkpoint inhibitors
-
3:22
impact of metastases-directed radiation therapy on cdk4/6 inhibitors treatment for mbc
-
4:28
cdk4/6 inhibitor maintained os benefit in advanced breast cancer - medpage today